vs
Side-by-side financial comparison of indie Semiconductor, Inc. (INDI) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
indie Semiconductor, Inc. is the larger business by last-quarter revenue ($58.0M vs $57.3M, roughly 1.0× RHYTHM PHARMACEUTICALS, INC.). indie Semiconductor, Inc. runs the higher net margin — -53.8% vs -83.0%, a 29.1% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -0.0%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 5.3%).
indie Semiconductor is a fabless semiconductor manufacturer focused on designing high-performance mixed-signal and embedded system-on-chip solutions for the automotive industry. Its products support advanced driver assistance systems, in-vehicle infotainment, connected car, and electric vehicle applications, serving global auto OEMs and tier 1 suppliers across major global markets.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
INDI vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.0M | $57.3M |
| Net Profit | $-31.2M | $-47.5M |
| Gross Margin | 37.3% | 91.6% |
| Operating Margin | -58.5% | -82.2% |
| Net Margin | -53.8% | -83.0% |
| Revenue YoY | -0.0% | 36.9% |
| Net Profit YoY | 9.1% | -9.6% |
| EPS (diluted) | $-0.16 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.0M | $57.3M | ||
| Q3 25 | $53.7M | $51.3M | ||
| Q2 25 | $51.6M | $48.5M | ||
| Q1 25 | $54.1M | $32.7M | ||
| Q4 24 | $58.0M | $41.8M | ||
| Q3 24 | $54.0M | $33.3M | ||
| Q2 24 | $52.4M | $29.1M | ||
| Q1 24 | $52.4M | $26.0M |
| Q4 25 | $-31.2M | $-47.5M | ||
| Q3 25 | $-38.3M | $-52.9M | ||
| Q2 25 | $-39.0M | $-46.6M | ||
| Q1 25 | $-34.5M | $-49.5M | ||
| Q4 24 | $-34.4M | $-43.3M | ||
| Q3 24 | $-49.7M | $-43.6M | ||
| Q2 24 | $-19.2M | $-32.3M | ||
| Q1 24 | $-31.2M | $-141.4M |
| Q4 25 | 37.3% | 91.6% | ||
| Q3 25 | 40.1% | 89.3% | ||
| Q2 25 | 40.6% | 88.6% | ||
| Q1 25 | 41.7% | 88.8% | ||
| Q4 24 | 42.6% | 90.9% | ||
| Q3 24 | 39.3% | 88.5% | ||
| Q2 24 | 42.2% | 89.9% | ||
| Q1 24 | 42.5% | 89.2% |
| Q4 25 | -58.5% | -82.2% | ||
| Q3 25 | -71.4% | -102.6% | ||
| Q2 25 | -83.3% | -93.4% | ||
| Q1 25 | -72.0% | -143.7% | ||
| Q4 24 | -58.4% | -98.6% | ||
| Q3 24 | -92.5% | -132.0% | ||
| Q2 24 | -70.0% | -139.2% | ||
| Q1 24 | -94.8% | -538.7% |
| Q4 25 | -53.8% | -83.0% | ||
| Q3 25 | -71.3% | -103.1% | ||
| Q2 25 | -75.6% | -96.1% | ||
| Q1 25 | -63.9% | -151.4% | ||
| Q4 24 | -59.2% | -103.6% | ||
| Q3 24 | -92.1% | -131.2% | ||
| Q2 24 | -36.6% | -110.9% | ||
| Q1 24 | -59.6% | -544.4% |
| Q4 25 | $-0.16 | $-0.73 | ||
| Q3 25 | $-0.19 | $-0.82 | ||
| Q2 25 | $-0.20 | $-0.75 | ||
| Q1 25 | $-0.18 | $-0.81 | ||
| Q4 24 | $-0.18 | $-0.71 | ||
| Q3 24 | $-0.28 | $-0.73 | ||
| Q2 24 | $-0.11 | $-0.55 | ||
| Q1 24 | $-0.19 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $145.5M | $388.9M |
| Total DebtLower is stronger | $353.4M | — |
| Stockholders' EquityBook value | $358.0M | $139.1M |
| Total Assets | $840.8M | $480.2M |
| Debt / EquityLower = less leverage | 0.99× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $145.5M | $388.9M | ||
| Q3 25 | $160.9M | $416.1M | ||
| Q2 25 | $192.6M | $291.0M | ||
| Q1 25 | $236.6M | $314.5M | ||
| Q4 24 | $274.2M | $320.6M | ||
| Q3 24 | $96.9M | $298.4M | ||
| Q2 24 | $112.3M | $319.1M | ||
| Q1 24 | $138.2M | $201.2M |
| Q4 25 | $353.4M | — | ||
| Q3 25 | $353.5M | — | ||
| Q2 25 | $352.5M | — | ||
| Q1 25 | $379.0M | — | ||
| Q4 24 | $381.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $358.0M | $139.1M | ||
| Q3 25 | $369.2M | $148.8M | ||
| Q2 25 | $390.4M | $-11.9M | ||
| Q1 25 | $405.6M | $18.9M | ||
| Q4 24 | $417.9M | $21.7M | ||
| Q3 24 | $458.6M | $11.2M | ||
| Q2 24 | $470.7M | $39.3M | ||
| Q1 24 | $432.9M | $61.6M |
| Q4 25 | $840.8M | $480.2M | ||
| Q3 25 | $855.1M | $506.9M | ||
| Q2 25 | $867.6M | $372.7M | ||
| Q1 25 | $909.0M | $386.7M | ||
| Q4 24 | $941.4M | $392.3M | ||
| Q3 24 | $797.5M | $363.6M | ||
| Q2 24 | $797.3M | $381.8M | ||
| Q1 24 | $803.6M | $258.7M |
| Q4 25 | 0.99× | — | ||
| Q3 25 | 0.96× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.93× | — | ||
| Q4 24 | 0.91× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-14.4M | $-25.4M |
| Free Cash FlowOCF − Capex | $-16.1M | — |
| FCF MarginFCF / Revenue | -27.8% | — |
| Capex IntensityCapex / Revenue | 3.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-71.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-14.4M | $-25.4M | ||
| Q3 25 | $-6.2M | $-26.6M | ||
| Q2 25 | $-7.6M | $-23.3M | ||
| Q1 25 | $-29.0M | $-40.4M | ||
| Q4 24 | $-6.7M | $-18.8M | ||
| Q3 24 | $-22.8M | $-25.2M | ||
| Q2 24 | $-19.7M | $-29.1M | ||
| Q1 24 | $-9.3M | $-40.7M |
| Q4 25 | $-16.1M | — | ||
| Q3 25 | $-10.3M | — | ||
| Q2 25 | $-13.6M | — | ||
| Q1 25 | $-31.4M | — | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-29.3M | — | ||
| Q2 24 | $-23.4M | — | ||
| Q1 24 | $-11.7M | — |
| Q4 25 | -27.8% | — | ||
| Q3 25 | -19.2% | — | ||
| Q2 25 | -26.4% | — | ||
| Q1 25 | -58.0% | — | ||
| Q4 24 | -14.8% | — | ||
| Q3 24 | -54.3% | — | ||
| Q2 24 | -44.7% | — | ||
| Q1 24 | -22.3% | — |
| Q4 25 | 3.0% | — | ||
| Q3 25 | 7.8% | — | ||
| Q2 25 | 11.6% | — | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 3.2% | — | ||
| Q3 24 | 12.1% | — | ||
| Q2 24 | 7.0% | — | ||
| Q1 24 | 4.4% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INDI
| Products | $55.7M | 96% |
| Services | $2.3M | 4% |
RYTM
Segment breakdown not available.
